TR200003084T2 - Paroxetine ascorbate - Google Patents

Paroxetine ascorbate

Info

Publication number
TR200003084T2
TR200003084T2 TR2000/03084T TR200003084T TR200003084T2 TR 200003084 T2 TR200003084 T2 TR 200003084T2 TR 2000/03084 T TR2000/03084 T TR 2000/03084T TR 200003084 T TR200003084 T TR 200003084T TR 200003084 T2 TR200003084 T2 TR 200003084T2
Authority
TR
Turkey
Prior art keywords
paroxetine ascorbate
paroxetine
ascorbate
useful
treatment
Prior art date
Application number
TR2000/03084T
Other languages
Turkish (tr)
Inventor
Urquhart Michael
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of TR200003084T2 publication Critical patent/TR200003084T2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Paroxetine askorbat, bazi CNS hastaliklarinin tedavisinde faydalidir.Paroxetine ascorbate is useful in the treatment of some CNS diseases.

TR2000/03084T 1998-04-25 1999-04-23 Paroxetine ascorbate TR200003084T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9808896.6A GB9808896D0 (en) 1998-04-25 1998-04-25 Novel compound

Publications (1)

Publication Number Publication Date
TR200003084T2 true TR200003084T2 (en) 2001-02-21

Family

ID=10831008

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/03084T TR200003084T2 (en) 1998-04-25 1999-04-23 Paroxetine ascorbate

Country Status (20)

Country Link
EP (1) EP1089995A1 (en)
JP (1) JP2002513019A (en)
KR (1) KR20010042977A (en)
CN (1) CN1297448A (en)
AP (1) AP2000001963A0 (en)
AU (1) AU3618499A (en)
BG (1) BG104940A (en)
BR (1) BR9909868A (en)
CA (1) CA2330055A1 (en)
EA (1) EA200001104A1 (en)
GB (1) GB9808896D0 (en)
HU (1) HUP0102116A3 (en)
ID (2) ID26654A (en)
IL (1) IL139081A0 (en)
NO (1) NO20005352L (en)
PL (1) PL343677A1 (en)
SK (1) SK15912000A3 (en)
TR (1) TR200003084T2 (en)
WO (1) WO1999055698A1 (en)
ZA (1) ZA200005912B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
IL159280A0 (en) * 2001-06-14 2004-06-01 Teva Pharma A process for preparing paroxetine hcl which limits formation of pink colored compounds
CA2471144C (en) 2002-01-09 2011-06-07 Emisphere Technologies, Inc. Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
CN110607554B (en) * 2018-10-30 2024-03-22 中国科学院化学研究所 Method for preparing medicine or medicine intermediate monocrystal or amorphous substance

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
ES2058061T3 (en) * 1985-10-25 1994-11-01 Beecham Group Plc DERIVED FROM PIPERIDINE, ITS PREPARATION AND ITS USE AS A MEDICINAL PRODUCT.
US5276042A (en) * 1993-04-16 1994-01-04 Crenshaw Roger T Treatment of premature ejaculation
ES2117557B1 (en) * 1996-02-29 1999-07-01 Ferrer Int NEW PROCEDURE FOR OBTAINING (-) - TRANS -N-P-FLUOROBENZOILMETIL-4- (P-FLUOROFENIL) -3- ((3,4- (METHYLENDIOXI) PHENOXI) METHYL) -PIPERIDINE.

Also Published As

Publication number Publication date
EA200001104A1 (en) 2001-04-23
ZA200005912B (en) 2001-12-19
IL139081A0 (en) 2001-11-25
ID26654A (en) 2001-01-25
ID26083A (en) 2000-11-23
WO1999055698A1 (en) 1999-11-04
NO20005352D0 (en) 2000-10-24
AP2000001963A0 (en) 2000-12-31
JP2002513019A (en) 2002-05-08
BR9909868A (en) 2000-12-19
HUP0102116A3 (en) 2002-12-28
CA2330055A1 (en) 1999-11-04
CN1297448A (en) 2001-05-30
PL343677A1 (en) 2001-08-27
KR20010042977A (en) 2001-05-25
BG104940A (en) 2001-09-28
NO20005352L (en) 2000-10-24
SK15912000A3 (en) 2001-04-09
GB9808896D0 (en) 1998-06-24
EP1089995A1 (en) 2001-04-11
HUP0102116A2 (en) 2002-05-29
AU3618499A (en) 1999-11-16

Similar Documents

Publication Publication Date Title
DE60022692D1 (en) (S, S) reboxetine for the treatment of migraine headache
TR200000059T2 (en) Pyridine derivatives
ID26043A (en) 1,2,5-TRIAZINA TRITIZED SUBSTITUTIONS FOR TREATMENT OF HIV INFECTIONS
DE60010098D1 (en) 28-EPIRAPALOGE
DE69925306D1 (en) TREATMENT OF HYDROCARBONGAS
PT1140944E (en) EPOTILONE DERIVATIVES AND THEIR USE AS ANTITUMATIC AGENTS
PT882021E (en) NEW PHENANTRIDINES
ES2184077T3 (en) NEW FENANTRIDINS REPLACED IN POSITION 6.
ATE315934T1 (en) THROMBOPOIETIN MIMETICS
CY1108610T1 (en) IL-2 Peptides and their derivatives and their use as therapeutic agents
DE69919700D1 (en) BRIDGED INDENOPYRROLOCARBAZOLE
DE60139466D1 (en) TREATMENT OF DIABETES
DE29809075U1 (en) Dynamic, display-like piece of jewelry
DE60115466D1 (en) ACTIVE PROCESSORS OF IMIDAZOPYRIDINE DERIVATIVES
DK1305037T3 (en) Painkiller
DK1204659T3 (en) Serotonergic benzofurans
TR200200278T2 (en) Calcilitic compositions
TR200003084T2 (en) Paroxetine ascorbate
TR200002939T2 (en) Paroxetine maleate
NO20005548D0 (en) Mykobakterieinhibitorer
TR200003083T2 (en) Paroxetine 10-camphorsulfonate for the treatment of CNS diseases.
NO20021429L (en) 1,4-dioxacycloalkan-2-one and 1,4-dioxacycloalken-2-one
DK1133297T3 (en) New therapeutic use of 1,6-dimethyl-8beta-hydroxymethyl-10alpha-methoxyergoline
IT1305242B1 (en) BUNCHER OF LEATHER.
ID29414A (en) TREATMENT OF DEPRESSION